During the past decade, Eye Wellness Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Eye Wellness Center" are "Thyroid Eye Disease" (2 trials), "Graves' Ophthalmopathy (GO)" (1 trials), "Graves' Orbitopathy" (1 trials), "Thyroid Associated Ophthalmopathies" (1 trials) and "Thyroid-Associated Ophthalmopathy" (1 trials). Many other conditions were trialed in "Eye Wellness Center" in a lesser frequency.

Most popular intervention types in "Eye Wellness Center" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Teprotumumab" (2 trials), "Placebo" (1 trials), "Placebo (Administered via subcutaneous injection)" (1 trials), "RVT-1401 (Administered via subcutaneous injection)" (1 trials) and "normal saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eye Wellness Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Eye Wellness Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Eye Wellness Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Eye Wellness Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".